Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Orexigen Therapeutics, Inc. (OREXQ)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues:  
    Net product sales  22.0       
    Royalties  5.910.61.3     
    Other  5.813.954.2     
Total revenues   [+]33.724.555.53.43.44.41.20.1
            Revenue growth   [+]37.8%-55.9%1519.6%0.0%-22.1%257.4%1298.9%0.0%
Cost of goods sold  8.00.00.00.00.00.00.00.0
Gross profit  25.724.555.53.43.44.41.20.1
            Gross margin  76.3%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative   [+]118.643.828.623.920.019.524.518.2
Research and development  38.040.857.456.773.712.828.147.4
Other operating expenses  -76.9       
EBITDA   [+]-50.2-59.8-30.4-77.1-89.9-27.4-50.9-65.1
            EBITDA margin  -149.0%-244.6%-54.7%-2249.2%-2623.3%-623.8%-4136.6%-73922.7%
Depreciation  0.40.20.10.10.30.40.50.5
EBITA  -50.7-60.1-30.5-77.2-90.2-27.9-51.4-65.5
            EBITA margin  -150.3%-245.5%-55.0%-2252.0%-2632.4%-633.8%-4175.1%-74465.9%
Amortization of intangibles  3.3       
EBIT   [+]-54.0-60.1-30.5-77.2-90.2-27.9-51.4-65.5
            EBIT margin  -160.1%-245.5%-55.0%-2252.0%-2632.4%-633.8%-4175.1%-74465.9%
Non-recurring items   [+]3.0       
Interest expense, net   [+]7.27.27.00.5-0.10.20.51.0
Other income (expense), net   [+]39.80.0      
Pre-tax income  -24.4-67.3-37.5-77.7-90.1-28.1-51.9-66.6
Income taxes  0.11.40.00.00.00.00.00.0
            Tax rate    0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -24.5-68.7-37.5-77.7-90.1-28.1-51.9-66.6
            Net margin  -72.8%-280.8%-67.6%-2265.8%-2628.2%-637.8%-4217.3%-75638.6%
   
Basic EPS   [+]($1.68)($5.24)($3.17)($0.80)($1.27)($0.58)($1.10)($1.67)
Diluted EPS   [+]($1.68)($5.24)($3.17)($0.80)($1.27)($0.58)($1.10)($1.67)
   
Shares outstanding (basic)   [+]14.613.111.896.570.748.347.439.9
Shares outstanding (diluted)   [+]14.613.111.896.570.748.347.439.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy